Abstract:Objective: To evaluate the prevalence of financial toxicity in women diagnosed with advanced/recurrent endometrial cancer and describe characteristics and qualitative aspects of financial stressors in this population. Methods: Women diagnosed with advanced/recurrent endometrial cancer at an urban academic center were invited to participate in a mixed-methods study to describe quality-of-life (QOL) and financial toxicity. Participants completed surveys including the EuroQOL-5D-5 (QOL), financial toxicity tool (COmprehensive Score for Financial Toxicity (COST)) and completed an interview inquiring about financial stressors. Descriptive statistics were performed, and interviews were transcribed and analyzed using Atlas.ti to identify themes. Results: Eighty-four women participated in the study reflecting a 90% response rate. Participants were a median age of 67.0 years and 6 (7%) self-identified as Hispanic. Most participants self-identified as White (41, 49%), followed by Black (35, 42%), and multiracial (8, 10%). Forty (49%) participants had advanced stage cancer while 42 (52%) had recurrent cancer, with endometrioid adenocarcinoma (41,50%) represented as the most common histology followed by serous carcinoma (18, 22%), carcinosarcoma (11, 13%), the remaining clear cell carcinoma/mixed/undifferentiated (14, 17%). The median financial toxicity score of the population was 28.0 (IQR: 21-35) out of 44.0, with 38.1% of participants reporting moderate financial toxicity (COST <26) and 8.3% reporting severe financial toxicity (COST <14). Lower financial toxicity scores (indicating poor financial wellness) were associated with younger age ( 65yo: 32.0; p<0.01), Black and multiracial participants compared to white participants (Black: 26.0, multiracial: 16.5, white: 33.0; p<0.05), Hispanic ethnicity (13.5 vs. 30.0; p<0.001), single marital status (26.0 vs. 33.0; p<0.05), and lower education (Less than college: 24.1 vs. college and above: 30.0; p<0.05). On multivariate linear regression, financial toxicity scores were associated positively with older age (B= 6.5, p<0.01) and non-single marital status (B=4.8, p<0.05) but were negatively associated with Hispanic ethnicity (B= -11.4, p<0.05). The median QOL score (health utility score) of the population was 0.80 (IQR: 0.71- 0.85) and this score was positively correlated with better financial wellness (higher financial toxicity score) (R= 0.3, p<0.05). Qualitative analysis of participant interviews found that participants experiencing financial toxicity reported themes of "forced retirement" and "forced work interruptions" (9, 11%) while those with financial wellness praised "quality insurance coverage" (19, 23%). Conclusion: Patients with advanced/recurrent endometrial cancer experience a high rate of financial toxicity. Although limited by sample size, financial toxicity was found to be significantly worse in younger, single, and Hispanic women. Further work to study this at-needs population should be done to identify causes and develop solutions to assist patients with financial stressors. Citation Format: Sarah A. Ackroyd, Gini Fleming, Nada Attia, Cheska Zoleta, Nita K. Lee. The cause behind the COST – exploring qualitative and quantitative aspects of financial toxicity in women diagnosed with advanced/recurrent endometrial cancer [abstract]. In: Proceedings of the AACR Special Conference on Endometrial Cancer: Transforming Care through Science; 2023 Nov 16-18; Boston, Massachusetts. Philadelphia (PA): AACR; Clin Cancer Res 2024;30(5_Suppl) nr A005.

Financial burden among metastatic breast cancer patients: a qualitative inquiry of costs, financial assistance, health insurance, and financial coping behaviors

Short-term and long-term financial toxicity from breast cancer treatment: a qualitative study

Financial toxicity among people with metastatic cancer: findings from the Cancer Experience Registry

Patient Perceived Financial Burden in Haematological Malignancies: A Systematic Review.

Investigation of Adverse-Event-related Costs for Patients with Metastatic Breast Cancer in a Real-World Setting.

Coping strategies and psychosocial resources among women living with metastatic breast cancer: A qualitative study

The social and economic toll of cancer survivorship: a complex web of financial sacrifice

As if the disease was not enough: coping with the financial consequences of cancer

Financial toxicity experienced by patients with breast cancer-related lymphedema: a systematic review

Abstract A005: The cause behind the COST – exploring qualitative and quantitative aspects of financial toxicity in women diagnosed with advanced/recurrent endometrial cancer

Patient recommendations for reducing long-lasting economic burden after breast cancer

Experienced financial toxicity among long-term cancer survivors: results from a national cross-sectional survey

Financial Toxicity Among Patients With Breast Cancer Worldwide

Arm morbidity and financial difficulty in breast cancer survivors

Patient-Reported Financial Burden of Treatment for Colon or Rectal Cancer

Patient and family financial burden associated with cancer treatment in Canada: a national study

Medical Financial Hardship Intensity and Financial Sacrifice Associated with Cancer in the United States

Cancer Survivors' Experiences with Financial Toxicity: A Systematic Review and Meta‐synthesis of Qualitative Studies

Association between patient-reported financial burden and catastrophic health expenditures in cancer survivors

Self-Reported Risk Factors for Financial Distress and Attitudes Regarding Cost Discussions in Cancer Care: A Single-Institution Cross-Sectional Pilot Study of Breast Reconstruction Recipients

Financial distress and medical financial hardship among young adult survivors of blood cancer